Citations

Clear

1280 citation(s) found for "Hong, Na".

Reaffirming the importance of nomenclature stability for Candida auris and its associated disease of candidiasis
Zhang, Sean X. , Hoog, Sybren G. de, Denning, David W. , Ahmed, Sarah , Alastruey-Izquierdo, Ana, Arendrup, Maiken Cavling, Borman, Andrew M. , Chen, Sharon, Chowdhary, Anuradha , Colgrove, Robert C. , Cornely, O., Filkins, Laura , Gangneux, Jean-Pierre, Gené, Josepa, Groll, A. H., Guillot, Jaques, HAASE, G., Jagielski, Tomasz , Kandemir, Hazal, Kidd, Sarah , Kwon-Chung, June, Mendoza, Leonel, Nguyen, M. Hong, Song, Yinggai , Stielow, J. Benjamin, Vilela, Raquel, Vitale, Roxana G. , Wengenack, Nancy L. , White, P. Lewis, Ostroski-Zeichner, Luis, Walsh, Thomas J., Alastruey‐Izquierdo, Ana , Arendrup, Maiken Cavling , Kandemir, Hazal , de Hoog, Sybren , Alastruey-Izquierdo, A , Arendrup, Maiken Cavling , Borman, Andrew , Filkins, Laura , Gené, Josepa , Groll, Andreas H , Halliday, Catriona , Hoenigl, Martin , Jagielski, Tomasz , Kandemir, Hazal , Kidd, Sarah E , Kus, Julianne V , Kwon-Chung, Kyung J , Lockhart, Shawn R. , Meis, Jacques F , Mendoza, Leonel , Nguyen, M Hong , Song, Yinggai , Vitale, Roxana G , Wengenack, Nancy L , White, Lewis , Walsh, Thomas J , Zhang, Sean X , Ahmed, Sarah A , Cornely, Oliver A. , Dufresne, Philippe J. , Gangneux, Jean‐Pierre , Groll, Andreas H. , Haase, Gerhard , Hawksworth, David L. , Hay, Roderick J. , Hoenigl, Martin , Hubka, Vít , Kus, Julianne V. , Kwon‐Chung, June , Meyer, Wieland , Sorrell, Tania Christine , Stielow, J. Benjamin , Vilela, Raquel, Ostrosky‐Zeichner, Luis

Mayo Clinic

Journal of Clinical Microbiology | December 23, 2025 | Volume: 64 | Issue: 2 | Pages: No page available

10.1128/jcm.01550-25 | PMID 41432443 Get It

Characterization of chromosome 5 aberrations in TP53 mutated myeloid neoplasms with ≥5% blasts: An International TP53 Investigators Network (iTiN) study
Yasin, Irfan , Stengel, Anna , Shao, Haipeng , Kaur, Amandeep , Patwardhan, Pranav Pramod , Bailey, Nathanael G. , Inamdar, Kedar , Patel, Anand , Pandiri, M, Sojitra, Payal , Tariq, Hamza , Pan, Zenggang , Wiredja, Danica , Tjota, Melissa Y. , Segal, Jeremy , Chang, Hong , Sallman, David A. , Tefferi, Ayalew , Badar, Talha , Perry, Anamarija M. , Haferlach, Claudia, Patwardhan, Pranav P , Tefferi, Ayalew , Badar, Talha , Venkataraman, Girish , Patel, Anand , Shao, Haipeng, Mason, Emily F. , Ghosh, Sharmila , Zhang, Jingjing , Wang, Peng , Arber, Daniel A. , Haferlach, Claudia , Lager, Angela M.

Mayo Clinic

Cancer | December 19, 2025 | Volume: 132 | Issue: 1 | Pages: No page available

10.1002/cncr.70210 | PMID 41417597 Get It

ABSTRACT Background Isolated chromosome 5/5q losses (–5/5q) without TP53 mutations are associated with favorable outcomes in myeloid neoplasms (MN) with <5% blasts. However, the clinical implication of concurrent −5/5q and TP53 aberrations in MN with ≥5% blasts is poorly understood. Methods Patients with TP53 ‐mutated MN carrying ≥5% blasts assessing the prognostic impact of ‐5/5q on 24‐month overall survival (OS24) were examined. Results Of 587 patients, 515 (88%) exhibited −5/5q overwhelmingly in the context of a complex karyotype (98.3% vs. 61.1% complex karyotype without −5/5q; p < .0001) and multihit TP53 allelic state (88.3% vs. 56.9%; p < .0001). Proportions of patients with blasts ≥20% were comparable between groups with and without −5/5q; p = 0.26. Notably, patients with −5/5q exhibited significantly fewer coalterations; p < .0001. Looking at outcomes, presence of −5/5q was associated with shorter median 24‐month overall survival (7.8 months vs. 11.2 months; p Log‐rank = .012), an effect restricted to subgroups with blasts <20% ( p = .039; N = 163), absent −7/7q ( p = .007; N = 225), or WHO5‐defined single hit allelic state ( p = 0.030; N = 91). Importantly, −5/5q retained independent adverse prognostic significance regardless of TP53 allelic state in a multivariable model. Furthermore, among the subset of 75 (13%) patients undergoing allogeneic stem cell transplantation, −5/5q predicted significantly shorter median 5‐year posttransplant survival (16.2 months vs. median not reached; p Log‐rank = .009). Conclusions These findings emphasize the independent prognostic relevance of chromosome 5/5q losses underscoring the clinical relevance of cytogenetic testing for −5/5q even in this high‐risk cohort.
Long-term considerations following living liver donation—Guidelines from the 2025 ILTS-iLDLT consensus conference on living liver donor safety
Sayed, Blayne A. , Jung, Dong-Hwan, Watt, Kymberly D. , Maluf, Daniel G. , Zhu, Zhi‐Jun , Eghtesad, Bijan , Minnee, Robert C. , James, Paul M., Man, Nancy Kwan, Liapakis, AnnMarie , Fipps, David C. , Taner, Timuçin , Wiggins, Chantal, Ascher, Nancy L. , Mas, Valeria, Chen, Chao‐Long, Vyas, Mary, Suk-Suh, Kyung, Broering, Dieter , Lerut, Jan , Olthoff, Kim M. , Rela, Mohamed, Fipps, David C , Sayed, Blayne A , Chan, Albert C Y , Rammohan, Ashwin , Shankar, Sadhana , Syn, Nicholas L. X. , Mathew, Johns Shaji , Bhangui, Prashant , Jung, Dong‐Hwan , Pomfret, Elizabeth , Roberts, John P. , Selzner, Markus , Chan, Albert , Chaudhary, Abhideep , Eguchi, Susumu , James, Paul, Goldaracena, Nicolás , Kodali, Sudha , Kim, Jong Man , Wiggins, Chantal, Terrault, Norah A. , Burra, Patrizia , Hirschfield, Gideon M. , Heimbach, Julie K. , Selzner, Nazia , Rela, Mohamed

Mayo Clinic

Liver Transplantation | December 18, 2025 | Volume: 32 | Issue: 8 | Pages: 1194-1209

10.1097/lvt.0000000000000790 | PMID 41410423 Get It

Living liver donation is a critical component for addressing organ shortage and improving outcomes for patients with end-stage liver disease. As the prevalence of living donor liver transplantation (LDLT) increases worldwide, understanding and optimizing long-term donor health is paramount. The 2025 International Liver Transplantation Society and International Living Donor Liver Transplantation Society (ILTS-iLDLT) Consensus Conference convened experts in the field of liver transplantation to establish evidence-based guidelines focused on the long-term medical, psychological, and social considerations following living liver donation. The aim of this working group was to integrate current evidence and expert consensus on donor follow-up protocols, risk assessment, and management strategies to promote long-term donor health, quality of life, and living liver donor programs globally to safeguard the welfare of this unique population.
Cortical asymmetry in autosomal dominant Alzheimer’s disease progression
Pérez-Millan, Agnès , Falgàs, Neus , Borrego-Écija, Sergi, Antonell, Anna, Fernández-Villullas, Guadalupe, Esteller-Gauxax, Diana, Tort-Merino, Adrià, Bargalló, Núria, Balasa, Mircea, Lladó, Albert, Chrem, Patricio, Day, Gregory S. , Devenney, Emma , Huey, Edward D. , Ikeuchi, Takeshi, Jucker, Mathias, Roh, Jee Hoon , Vitali, Paolo , Ortíz, Ana Luisa Sosa, Llibre-Guerra, Jorge J, Gordon, Brian A., Sánchez-Valle, Raquel, (DIAN), The Dominantly Inherited Alzheimer Network, Daniels, Alisha , Courtney, Laura, Ziegemeier, Angela, Skrbec, Karina, Hellm, Cortaiga, Martin, Mariana , Ziegemeier, Ellen , Bartzel, Jamie, Xiong, Chengie , Xu, Xiong, Lu, Ruijin, Li, Yan , Nie, Yuzheng , Gremminger, Emily, Perrin, Richard J. , Franklin, Erin , Ibanez, Laura, Jerome, Gina, Stauber, Jennifer, Baker, Bryce, Minton, Matthew, Cruchaga, Carlos C, Goate, Alison M, Renton, Alan E, Picarello, Danielle M. , Benzinger, Tammie L S, Hornbeck, Russ C. , Chen, Allison, Chen, Charles D., Flores, Shaney, Joseph-Mathurin, Nelly, Jackson, Kelley, Keefe, Sarah , Koudelis, Deborah, Massoumzadeh, Parinaz , Nicklaus, Joyce , Pulizos, Christine, Wang, Qing, Sabaredzovic, Edita, Scott, Jalen , Simmons, Ashlee, Rizzo, Jacqueline, Vlassenko, Andrei G. , Wang, Yong, Hassenstab, Jason, Smith, Jennifer, Stout, Sarah, Marsh, Jacob, Morris, John C, Barthélemy, Nicolas R. , Xu, Jinbin , Ikonomović, Snežana, Graff-Radford, Neill R, Farlow, Martin R. , Chhatwal, Jasmeer P. , Maa, Courtney, Ishiguro, Takanobu , Ishii, Kenji, Senda, Michio, Salloway, Stephen , Bechara, Jacob A, Martins, Ralph, Fox, Nick C, Ryan, Natalie S. , Laske, Christoph , Timofejavaite, Reda, Kuder-Buletta, Elke, Graber-Sultan, Susanne, Obermueller, Ulrike, Xiong, Chengjie , Rödenbeck, Yvonne, Vӧglein, Jonathan, Méndez, Patricio Chrem, Vazquez, Silvia, Leon, Yudy Milena, Ramirez, Laura, Baena, Ana , Bocanegra, Yamile , Levey, Allan, Johnson, Erik C B, Seyfried, Nicholas T. , Ringman, John M. , Fagan, Anne M. , Mori, Hiroshi, Lopera, Francisco , Goate, Alison , Hassenstab, Jason , Borrego‐Écija, Sergi , Pérez‐Millan, Agnès , Ikeuchi, T , Vöglein, Jonathan , Roh, Jee Hoon , Vitali, Paolo , Gordon, Brian A , Bateman, Randall J , Sánchez-Valle, Raquel , Day, Gregory S , Xiong, Chengjie , Hassenstab, Jason , Borrego-Écija, Sergi , Goate, Alison M , Bosch, Beatríz , Antonell, Anna, Fernández‐Villullas, Guadalupe , Esteller, Diana , Tort‐Merino, Adrià , Balasa, Mircea , Lladó, Albert , Aguillon, David , Ikeuchi, Takeshi , Jucker, Mathias , Kasuga, Kensaku , Vöglein, Jonathan , Llibre‐Guerra, Jorge J. , Gordon, Brian A. , McDade, Eric , Bateman, Randall J. , Sánchez‐Valle, Raquel , Supnet, Charlene , Lu, Ruijin, Wang, Guoqiao , Ibanez, Laura , Cruchaga, Carlos , Fulton‐Howard, Brian , Banks, Jessica N , Flores, Shaney , Goyal, Manu S. , Hobbs, Diana A. , Joseph‐Mathurin, Nelly , McCullough, Austin , McKay, Nicole S. , Wang, Yong , Smith, Jennifer, Stout, Sarah H., Aschenbrenner, Andrew J. , Karch, Celeste M. , Marsh, Jacob A. , Holtzman, David M. , Berman, Sarah , Graff‐Radford, Neill R. , Senda, Michio , Niimi, Yoshiki , Schofield, Peter R. , Brooks, William S. , Bechara, Jacob , Cash, David M. , Laske, Christoph , Fougère, Christian la , Reischl, Gerald , Lee, Jae Hong , Allegri, Ricardo , Surace, Ezequiel , Vazquez, Silvia, Ramírez, Laura, Serna, Laura, Johnson, Erik C. B. , Masters, Colin L. , Noble, James M. , Lopera, Francisco Javier

Mayo Clinic

Brain Communications | December 18, 2025 | Volume: 8 | Issue: 1 | Pages: No page available

10.1093/braincomms/fcaf488 | PMID 41523185 Get It

Abstract The cortical asymmetry index evaluates the cortical thickness asymmetry between hemispheres. We investigated cortical asymmetry index in asymptomatic and symptomatic mutation carriers of autosomal dominant Alzheimer’s disease to explore the brain asymmetry within the Alzheimer’s disease continuum. Sixty baseline T1-weighted MRI scans were obtained from the Clinic Barcelona cohort. Baseline and longitudinal MRI data from 564 participants within the dominantly inherited Alzheimer network observational study were used as an independent, confirmatory cohort. Cerebrospinal fluid and plasma neurofilament light chain levels were included when available. Cortical thickness was calculated using Freesurfer and cortical asymmetry index was calculated via an open-source pipeline. Cross-sectional analyses examined cortical asymmetry index differences based on clinical classification and APOE ε4 status, adjusting for age, sex and estimated years from onset, while correlations were assessed with age, estimated years from onset, mini-mental state examination scores, and neurofilament light. Longitudinal cortical asymmetry index evolution was modelled using generalized additive models in the dominantly inherited Alzheimer network observational study cohort, incorporating age, sex, and the interaction between group and estimated years from onset. The cortical asymmetry index successfully distinguished asymptomatic mutation carrier and symptomatic mutation carriers from healthy controls in the Clinic Barcelona cohort and symptomatic mutation carriers from controls in dominantly inherited Alzheimer network observational study. Higher cortical asymmetry index in mutation carriers (asymptomatic mutation carrier and symptomatic mutation carriers combined) and in symptomatic mutation carriers were associated with higher plasma neurofilament light levels, a closer proximity to symptom onset, and lower mini-mental state examination in the Clinic Barcelona cohort. In the dominantly inherited Alzheimer network observational study cohort, mutation carriers exhibited increased cortical asymmetry index compared to controls and correlated with elevated neurofilament light (plasma and Cerebrospinal fluid), lower mini-mental state examination, and a closer proximity to symptom onset. APOE3/3 carriers showed greater asymmetry than other APOE genotypes and significant cortical asymmetry index differences between asymptomatic mutation carrier and symptomatic mutation carriers. Longitudinally, cortical asymmetry index increased over time significantly in symptomatic mutation carriers. These findings underscore brain asymmetry as a potential biomarker for early Alzheimer’s disease progression in autosomal dominant Alzheimer’s disease, with implications for detection and monitoring tracking disease-related neuroanatomical changes.
Boron‐Doped Nano‐Crystalline Coated Carbon Fibers for Phasic Dopamine Sensing
Higham, Simon , Cabrera, Juan M. Rojas , Kwak, Youngjong , Hong, Lydia, Chambers, Andre , Nadarajah, Athavan, León, Sorel E. De , Jung, Young Jun , Jalilinejad, Negin , Jang, Dong Pyo , Shin, Hojin , Tong, Wei , Higham, Simon J , Blaha, Charles , Lee, Kendall, Shin, Hojin , Tong, Wei , Rojas Cabrera, Juan M , Hong, Lydia, Blaha, Charles D. , Oh, Yoonbae , Lee, Kendall , Stacey, Alastair D. , Cloherty, Shaun Liam , Ibbotson, Michael R. , Garrett, David J. , Prawer, Steven

Mayo Clinic

Advanced Healthcare Materials | December 18, 2025 | Volume: 15 | Issue: 15 | Pages: No page available

10.1002/adhm.202503945 | PMID 41409014 Get It

ABSTRACT Real time, chronic electrochemical detection of neurotransmitters will provide a positive step in the treatment and understanding of neurological disease. However, current electrodes using carbon fibers (CF) fail to perform chronically. While diamond‐based coatings show promise in improving their longevity, achieving a uniform layer of such coatings on CFs is challenging, and the electrodes often lose sensitivity after coating. In this work, a complete and uniform boron‐doped nanocrystalline material grown in a diamond reactor (B‐NCD) was developed to coat CF microelectrodes for neurochemical sensing. The coating was characterized electrically, optically, mechanically, and chemically. The B‐NCD coated CF electrodes were able to detect phasic dopamine at a sensitivity comparable to the most widely used alternatives (uncoated and PEDOT:Nafion coated CFs). During biofouling testing, the B‐NCD coated CF electrodes demonstrated better stability than uncoated CFs and comparable performance to PEDOT:Nafion coated CFs. Moreover, B‐NCD exhibited no signs of degradation during consecutive FSCV applications, while uncoated and PEDOT:Nafion coated CF electrodes degraded significantly over time. Furthermore, the B‐NCD coating supported the survival and development of neurons and astrocytes in vitro, exhibited excellent adhesion and durability during mechanical bending testing, and enabled successful in vivo recording of phasic dopamine release in the rat brain. Overall, B‐NCD coated CFs present as an ideal candidate for chronic, flexible neural implantable electrodes for long‐term neurochemical monitoring.
Navigating the Risks Beyond the Label: Unpacking Global Nutritional Supplement Safety
Wardenaar, Floris C. , Burns, Stephen F. , Campos, Marcus Vinícius Simões de , Chan, Yat C. , Claassen-Smithers, Amanda , Dunshea-Mooij, Christel A.E. , Haddou, Salah Eddine, Hoogervorst, Daan , García, P. , Garthe, Ina, Nugent, Anne P. , Aly, Maged Ossama , Schott, Kinta D. , Sekiguchi, Yasuki , Slater, Gary , Speers, Naomi , Campos, Marcus , Chan, Yat , Dunshea-Mooij, Christel , Jagim, Andrew R , Garcia, Pedro Reinaldo , Nugent, Anne P , Aly, Maged Ossama , Saunders, Bryan , Schott, Kinta D , Sekiguchi, Yasuki , Slater, Gary , Speers, Naomi , Stratton, Matthew T , Aussieker, Thorben , Jagim, Andrew R. , Stratton, Matthew T.

Mayo Clinic

International Journal of Sport Nutrition and Exercise Metabolism | December 17, 2025 | Volume: 36 | Issue: 2 | Pages: 134-166

10.1123/ijsnem.2025-0177 | PMID 41468235 Get It

Nutritional supplement use is common among athletes aiming to enhance performance, recovery, and health. However, variable regulatory frameworks and limited safety oversight create risks for inadvertent doping violations. This article provides a global overview of supplement use, relevant authorities, legislation, and safety measures, with a focus on third-party testing (TPT) as a risk-mitigation strategy. Data from six global regions—Africa, Asia, Australia/New Zealand, Europe, Latin America, and North America—were synthesized from peer-reviewed studies, governmental sources, and regional expert contributions. Reported supplement use ranged from 7% to 100% among athletes (variability within regions), with protein powders, vitamins/minerals, creatine, caffeine, and sports drinks being most prevalent. High-risk products (potential anti-doping rule violations), including certain herbal blends, preworkouts, and weight-management supplements, were reported across all regions. While some countries have robust regulatory systems, most lack harmonized or enforceable safety frameworks. TPT programs, which independently verify products for prohibited substances, remain concentrated in the global northwest (Europe, North America, and Australia/New Zealand); awareness and use of TPT certification vary widely, and even in regions with established systems, athlete adherence is inconsistent. Barriers to low-risk supplement use are limited TPT availability, cost, differences in labeling (including language), and cultural factors. Firsthand experiences and perceptions highlight widespread misconceptions about supplement safety and certification. The authors recommend expanded athlete and team-around-the-athlete education, improved global access to TPT low-risk supplements, and policy initiatives to harmonize safety standards. This work emphasizes the need for coordinated international efforts to protect athlete health and integrity while allowing access to evidence-based supplementation.
Development of a novel elastase-induced saccular aneurysm model in rats suitable for testing endovascular devices: An experimental animal study
Ueki, Yasuhito , Bayraktar, Esref Alperen , Ognard, Julien, Hajj, G El , Ding, Yonghong , Dai, Daying , Rinaldo, Lorenzo , Kadirvel, Ramanathan , Kallmes, David F. , Bayraktar, Esref Alperen , El Hajj, Gerard , Ding, Yong-Hong , Kadirvel, Ram , Dai, Daying , Ognard, Julien

Mayo Clinic

Interventional Neuroradiology | December 15, 2025 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1177/15910199251399755 | PMID 41396675 Get It

Background Animal models are essential for evaluating endovascular device safety and efficacy. Rats offer advantages, such as genetic manipulability, lower cost, and shorter healing and breeding cycles, compared to large animals. These features support studying aneurysm healing mechanisms and enable high-throughput testing. We developed an optimal rat aneurysm model for device evaluation. Methods Saccular aneurysms were created at the origins of the left renal artery (LRA) with acetylsalicylic acid (ASA) (LRA/ASA group, n = 7); the right common iliac artery (RCIA) with ASA alone (RCIA/ASA group, n = 6) or ASA plus clopidogrel (CLP) (RCIA/ASA + CLP group, n = 7); and the left common iliac artery (LCIA) with ASA + CLP (LCIA/ASA + CLP group, n = 7). The origins of these arteries were surgically exposed. During temporary ligation of the vessel origin, the vessel was bisected and endoluminal elastase was incubated in the proximal stump for 10 min, followed by release of the proximal ligation and permanent ligation of the stump. Angiographical and histological analysis were performed 4 weeks post-procedure. Results Follow-up digital subtraction angiography revealed mean ± standard deviation aneurysm height/neck dimensions of 1.2 ± 0.4/1.2 ± 0.1, 2.9/3.1, 2.3 ± 0.6/1.9 ± 0.3, and 2.1 ± 0.6/2.0 ± 0.4 mm for the LRA/ASA, RCIA/ASA, RCIA/ASA + CLP, and LCIA/ASA + CLP groups, respectively. The survival rate was 29%, 17%, 71%, and 86% in the LRA/ASA, RCIA/ASA, RCIA/ASA + CLP, and LCIA/ASA + CLP groups, respectively. Histopathological analysis of these aneurysms confirmed the absence of the internal elastic lamina and revealed aneurysmal changes in the arterial wall, resembling the pathological findings observed in human aneurysm specimens. Conclusions Common iliac aneurysm models with ASA + CLP can be used to evaluate the safety and efficacy of endovascular devices.
Magnetic resonance elastography characterization of meningioma mechanical properties for improved neurosurgical planning and resection: a prospective cohort study
Bai, Shengjun, Zeng, Yu , Hong, Yang , Han, Shuai , Zhang, Tianhe, Guo, Mingzhe, Wu, Jianqi , Sheng, Yiyang, Wu, Anhua , Zheng, Keni, Huston Iii, John, Jiao, Niandong, Cheng, Wen , Bai, Shengjun, Zheng, Keni , Zhang, Tianhe, Guo, Mingzhe, Liu, Tianqi , Manduca, Armando , Huston, John , Wu, Qi‐Jun , Jiao, Niandong , Yin, Ziying , Shi, Yu

Mayo Clinic

International Journal of Surgery | December 11, 2025 | Volume: 112 | Issue: 3 | Pages: 6859-6871

10.1097/js9.0000000000004199 | PMID 41376349 Get It

Background: Accurate characterization of tumor stiffness and adhesion is crucial when surgically resecting meningiomas. Currently, such determinations are difficult to ascertain through standard preoperative imaging diagnostics and clinical experience. Herein, we explored magnetic resonance elastography (MRE) as a means of assessing these parameters and thereby improving neurosurgical resections. Methods: This prospective study of 193 patients with meningiomas involved three distinct patient subsets (cohort 1, 88 [2017–2021]; cohort 2, 55 [2022–2023]; cohort 3, 50 [2023–2024]. We analyzed preoperatively obtained MRE data on meningioma stiffness (cohorts 1 and 2) and adhesion (cohort 2) for accuracy, while matching subjects with or without MRE studies (cohort 3, 1:1 ratio) to define the role of preoperative MRE in improving operative outcomes. Results: Areas under the curve (AUCs) for MRE in gauging meningioma stiffness and adhesion were 0.87 and 0.89, respectively. Both parameters significantly surpassed empiric predictions of stiffness and adhesion rendered by surgeons and radiologists, based on routine magnetic resonance imaging (MRI). MRE-determined stiffness measures independently correlated with prolonged resection duration, whereas MRE-assessed adhesion showed independent associations with increased blood loss, longer duration of tumor resection, and higher risk of pial injury. Ultimately, results based on cohort 3 demonstrated that MRE has great potential in this setting to improve neurosurgical procedures by significantly reducing intraoperative bleeding, resection duration, and risks of pial injury. Conclusion: MRE is a promising, noninvasive tool for accurately assessing meningioma stiffness and adhesion, standing to improve the precision and safety of needed surgical intervention.
Navigating Adolescent Mental Health in the Age of Artificial Intelligence
Ng, Stephanie , Ng, Stephanie

Mayo Clinic

JAACAP Connect | December 8, 2025 | Volume: 13 | Issue: 1 | Pages: No page available

10.62414/001c.150329 Get It

The adolescent mental health landscape is rapidly evolving as AI reshapes how young people connect and navigate developmental challenges. From the known harms of machine learning algorithms reinforcing pathology on social media to the emerging risks of generative AI fostering emotional attachments in vulnerable youth and future risks of agentic AI pursuing its users proactively, AI’s evolution will have important implications for clinical practice and public policy.
Cyst-X: AI-Powered Pancreatic Cancer Risk Prediction from Multicenter MRI in Centralized and Federated Learning
Bağcı, Ulaş , Pan, Hongyi , Keleş, Elif , Seyithanoğlu, Deniz, Zhang, Zheyuan , Aktaş, Halil , Bejar, Andrea , Hong, Ziliang , Taktak, Yavuz , Kartal, Gulbiz, Cebeci, Timurhan , Gonzalez, Maria , Zhao, Lili , Agarunov, Emil, Salanitri, Federica Proietto , Tiwari, Pallavi , Bruno, Marco J. , Huang, Chenchang, Bolan, Candice W. , Gonda, Tamas A. , Miller, Frank, Keswani, Rajesh N. , Zhao, Lili , Bagci, Ulas , Durak, Görkem , Medetalibeyoğlu, Alpay , Ertürk, Şükrü Mehmet , Gonzalez, Maria, Velichko, Yury , Spampinato, Concetto , Tiwari, Pallavi , Xu, Ziyue , Jambawalikar, Sachin , Schoots, Ivo G. , Huang, Chenchang, Wallace, Michael B.

Mayo Clinic

No container title available | December 8, 2025 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-7236860/v1 Get It

Abstract Pancreatic cancer, projected to become the second-deadliest malignancy in Western societies by 2030, requires urgent innovations in early detection and risk stratification. Intraductal papillary mucinous neoplasms (IPMNs) represent critical precursor lesions, but current clinical guidelines demonstrate suboptimal accuracy in malignancy prediction, leading to either unnecessary surgeries or missed opportunities for early intervention. In this paper, we present Cyst-X, an artificial intelligence (AI) framework that accurately predicts IPMN malignant transformation using multicenter magnetic resonance imaging (MRI) data. Unlike most previous approaches that rely on computed tomography (CT), our method capitalizes on the superior soft tissue contrast of MRI, allowing for more precise identification of subtle imaging biomarkers. We developed and validated deep learning models on 723 T1-weighted and 738 T2-weighted MRI scans from 764 patients among seven international institutions, demonstrating significantly superior performance (AUC=0.82) compared to current clinical (Kyoto) guidelines (AUC=0.75) and expert radiologists. AI-based imaging features correlate strongly with clinically recognized malignancy markers, providing potential biologically relevant insights. This approach holds promise to significantly refine clinical decision-making, reduce unnecessary surgeries, and better identify high-risk IPMN patients for timely intervention. Our approach integrates a novel pancreas segmentation network with robust classification models that identify subtle imaging biomarkers associated with malignancy risk. Importantly, we demonstrate that these models retain high performance in a privacy-preserving federated learning setting, where institutions collaboratively train AI models without exchanging patient data to address key regulatory and ethical barriers. We publicly release the Cyst-X dataset--the first large-scale, multi-center pancreatic cyst MRI collection--to accelerate research in this field. This study addresses a critical clinical need while establishing technical foundations for privacy-preserving AI in radiology that could transform pancreatic cancer management through earlier intervention and reduced unnecessary procedures. The dataset can be accessed at https://osf.io/74vfs/, and the source code for our deep learning segmentation and classification models is available at https://github.com/NUBagciLab/Cyst-X.